Research scientists have long been forced to make compromises when choosing between fresh or frozen hepatocytes. No longer. You now have a new option.

So whether you are creating the next cure for an infectious disease such as hepatitis or malaria, building innovative gene therapies, targeting NASH, or testing your small molecule for metabolism or toxicology, with HepaCur™ Fresh hepatocytes you get a uniquely better option for answering your liver-specific questions.

Patent Notice